474
Views
25
CrossRef citations to date
0
Altmetric
Reviews

Drugs in preclinical and early-stage clinical development for pancreatic cancer

, &
Pages 143-152 | Published online: 05 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jun-ya Ueda, Sirivan Athikomkulchai, Ryuta Miyatake, Ikuo Saiki, Hiroyasu Esumi & Suresh Awale. (2014) (+)-Grandifloracin, an antiausterity agent, induces autophagic PANC-1 pancreatic cancer cell death. Drug Design, Development and Therapy 8, pages 39-47.
Read now
Enza Lonardo, Javier Frias-Aldeguer, Patrick C. Hermann & Christopher Heeschen. (2012) Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness. Cell Cycle 11:7, pages 1282-1290.
Read now

Articles from other publishers (22)

Fabiola De Luca, Carla Di Chio, Maria Zappalà & Roberta Ettari. (2022) Dihydrochalcones as Antitumor Agents. Current Medicinal Chemistry 29:30, pages 5042-5061.
Crossref
Yueqin Feng, Yuguan Jiang & Fengjin Hao. (2021) GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments. Journal of Translational Medicine 19:1.
Crossref
Xiao‐Fang Wang, Wen‐Feng Huang, Jian Nie, Yong Zhou, Ding‐Wu Tan & Ji‐Hao Jiang. (2018) Toxicity of chemotherapy regimens in advanced and metastatic pancreatic cancer therapy: A network meta‐analysis. Journal of Cellular Biochemistry 119:7, pages 5082-5103.
Crossref
Keith Unger, Khyati Y. Mehta, Prabhjit Kaur, Yiwen Wang, Smrithi S. Menon, Shreyans K. Jain, Rose A. Moonjelly, Shubhankar Suman, Kamal Datta, Rajbir Singh, Paul Fogel & Amrita K. Cheema. (2018) Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma. Oncotarget 9:33, pages 23078-23090.
Crossref
Gui‐Feng Liu, Gui‐Jie Li & Hang Zhao. (2017) Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta‐Analysis. Journal of Cellular Biochemistry 119:1, pages 511-523.
Crossref
Su-You Liu, Na Xu, Li-Jun Liu, Ying-Xiong Wang & Da-You Ma. (2019) An Efficient Synthesis of Angelmarin and its Analogs. Natural Product Communications 12:12, pages 1934578X1701201.
Crossref
Khyati Y. Mehta, Hung-Jen Wu, Smrithi S. Menon, Yassi Fallah, Xiaogang Zhong, Nasser Rizk, Keith Unger, Mark Mapstone, Massimo S. Fiandaca, Howard J. Federoff & Amrita K. Cheema. (2017) Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget 8:40, pages 68899-68915.
Crossref
Hai Xuan Nguyen, Truong Nhat Van Do, Tho Huu Le, Mai Thanh Thi Nguyen, Nhan Trung Nguyen, Hiroyasu Esumi & Suresh Awale. (2016) Chemical Constituents of Mangifera indica and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line . Journal of Natural Products 79:8, pages 2053-2059.
Crossref
Mariam F. Eskander, Lindsay A. Bliss & Jennifer F. Tseng. (2016) Pancreatic adenocarcinoma. Current Problems in Surgery 53:3, pages 107-154.
Crossref
Brian B. Haab, Ying Huang, Seetharaman Balasenthil, Katie Partyka, Huiyuan Tang, Michelle Anderson, Peter Allen, Aaron Sasson, Herbert Zeh, Karen Kaul, Doron Kletter, Shaokui Ge, Marshall Bern, Richard Kwon, Ivan Blasutig, Sudhir Srivastava, Marsha L. Frazier, Subrata Sen, Michael A. Hollingsworth, Jo Ann Rinaudo, Ann M. Killary & Randall E. Brand. (2015) Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLOS ONE 10:10, pages e0139049.
Crossref
Mai Thanh Thi Nguyen, Nhan Trung Nguyen & Suresh Awale. 2015. Mechanism of the Anticancer Effect of Phytochemicals. Mechanism of the Anticancer Effect of Phytochemicals 95 110 .
Roger B. Slee, Brenda R. Grimes, Ruchi Bansal, Jesse Gore, Corinne Blackburn, Lyndsey Brown, Rachel Gasaway, Jaesik Jeong, Jose Victorino, Keith L. March, Riccardo Colombo, Brittney-Shea Herbert & Murray Korc. (2014) Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS1 Kinase Inhibitor NMS-P715. Molecular Cancer Therapeutics 13:2, pages 307-315.
Crossref
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, MAKOTO SUEISHI & TAKANOBU YOSHIDA. (2014) Frizzled-2: A potential novel target for molecular pancreatic cancer therapy. Oncology Letters 7:1, pages 74-78.
Crossref
Martyn Inman, Andrea Visconti, Chao Yan, David Siegel, David Ross & Christopher J. Moody. (2014) Antitumour indolequinones: synthesis and activity against human pancreatic cancer cells. Organic & Biomolecular Chemistry 12:27, pages 4848.
Crossref
Bhushan Shakya, Paras Nath Yadav, Jun-ya Ueda & Suresh Awale. (2014) Discovery of 2-pyridineformamide thiosemicarbazones as potent antiausterity agents. Bioorganic & Medicinal Chemistry Letters 24:2, pages 458-461.
Crossref
Hai Xuan Nguyen, Mai Thanh Thi Nguyen, Thy Anh Nguyen, Nhi Y Thi Nguyen, Dao Anh Thi Phan, Phuoc Ho Thi, Trong Huu Phan Nguyen, Phu Hoang Dang, Nhan Trung Nguyen, Jun-ya Ueda & Suresh Awale. (2013) Cleistanthane diterpenes from the seed of Caesalpinia sappan and their antiausterity activity against PANC-1 human pancreatic cancer cell line. Fitoterapia 91, pages 148-153.
Crossref
Patrick C. Hermann, Sara M. Trabulo, Bruno Sainz, Anamaria Balic, Elena Garcia, Stephan A. Hahn, Mallaredy Vandana, Sanjeeb K. Sahoo, Patrizia Tunici, Annette Bakker, Manuel Hidalgo & Christopher Heeschen. (2013) Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts. PLoS ONE 8:6, pages e66371.
Crossref
Wudan Yan, Wayne D. Bowen, Russell Hopson, Abraham E. Mathew & James N. Jacob. (2019) Biological Studies of Turmeric Oil, Part 2: Isolation and Characterization of Turmeric Oil Components; Cytotoxic Activity against Pancreatic Cancer Cells. Natural Product Communications 8:6, pages 1934578X1300800.
Crossref
Markus D. Siegelin. (2013) Inhibition of the mitochondrial Hsp90 chaperone network: A novel, efficient treatment strategy for cancer?. Cancer Letters 333:2, pages 133-146.
Crossref
Karoly Szepeshazi, Andrew V. Schally, Norman L. Block, Gabor Halmos, Mehrdad Nadji, Luca Szalontay, Irving Vidaurre, Andrew Abi-Chaker & Ferenc G. Rick. (2013) Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108. Oncotarget 4:5, pages 751-760.
Crossref
Guido Bocci, Anna Fioravanti, Paola Orlandi, Teresa Di Desidero, Gianfranco Natale, Giovanni Fanelli, Paolo Viacava, Antonio Giuseppe^Naccarato, Giulio Francia & Romano Danesi. (2012) Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1. Neoplasia 14:9, pages 833-IN11.
Crossref
Xiangrong Zhang, Hongxia Xu, Xu Zhang, Sukesh Voruganti, Srinivasan Murugesan, Dwayaja H. Nadkarni, Sadanandan E. Velu, Ming-Hai Wang, Wei Wang & Ruiwen Zhang. (2012) Preclinical Evaluation of Anticancer Efficacy and Pharmacological Properties of FBA-TPQ, a Novel Synthetic Makaluvamine Analog. Marine Drugs 10:12, pages 1138-1155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.